| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $1.2M | -15.8% | +16.2% |
| SG&A Expense | $1.6M | +8.1% | -17.0% |
| Operating Income | -$2.8M | +3.6% | +5.5% |
| Pre-tax Income | -$2.8M | +4.3% | -173.9% |
| Income Tax | $0 | — | — |
| Net Income | -$2.8M | +4.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.4M | +34.1% | -80.7% |
| Accounts Receivable | $0 | — | — |
| Current Assets | $2.2M | +23.9% | -70.8% |
| Total Assets | $4.3M | +8.7% | -56.0% |
| Current Liabilities | $1.8M | +24.4% | +32.0% |
| Total Liabilities | $2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.3M | — | — |
| Capital Expenditures | $15K | — | — |
| Investing Cash Flow | -$99K | — | — |
| Financing Cash Flow | $5.3M | — | — |
| Free Cash Flow | -$8.3M | — | — |
| -173.9% |
| EPS (Basic) | -$0.67 | -272.2% | -294.1% |
| EPS (Diluted) | -$0.67 | -272.2% | -294.1% |
| +17.0% |
| +17.6% |
| Stockholders' Equity | $2.3M | +2.3% | -71.7% |